(19)
(11) EP 1 109 806 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
29.10.2003 Bulletin 2003/44

(45) Mention of the grant of the patent:
27.08.2003 Bulletin 2003/35

(21) Application number: 00940418.7

(22) Date of filing: 30.06.2000
(51) International Patent Classification (IPC)7: C07D 405/12, C08B 37/00, A61K 31/445, A61K 31/4525, A61P 25/00
(86) International application number:
PCT/EP0006/121
(87) International publication number:
WO 0100/2393 (11.01.2001 Gazette 2001/02)

(54)

COMPLEXES OF PAROXETINE, WITH CYCLODEXTRINS OR CYCLODEXTRIN DERIVATES

KOMPLEXE VON PAROXETIN MIT CYCLODEXTRIN ODER CYCLODEXTRIN DERIVATEN

COMPLEXES DE PAROXETINE, AVEC DES CYCLODEXTRINES ET DES DERIVES DE LA CYCLODEXTRINE

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 01.07.1999 IT MI991459
17.11.1999 IT MI992406

(43) Date of publication of application:
27.06.2001 Bulletin 2001/26

(73) Proprietor: Italfarmaco S.p.A.
20128 Milano (IT)

(72) Inventors:
  • MASCAGNI, Paolo
    I-20058 Villasanta (IT)
  • BOTTONI, Giuseppe
    I-24124 Bergamo (IT)

(74) Representative: Gervasi, Gemma, Dr. et al
Notarbartolo & Gervasi S.p.A., Corso di Porta Vittoria, 9
20122 Milano
20122 Milano (IT)


(56) References cited: : 
WO-A-00/08016
US-A- 4 007 196
 WO-A-99/16440
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).